2 most recent filings and news items mentioning LSTA. Updated every 60 seconds.
M&AJul 17, 2026Neutral
The Company amended its merger agreement with Kuva Labs to extend the Outside Date from July 17 to July 21, 2026. This adjustment follows an extension of the time available to consummate the business combination.
View filing at SEC.gov →
M&AMay 29, 2026Neutral
Lisata Therapeutics and Kuva Labs amended their merger agreement dated March 6, 2026, revising the offer price to $4.00 per share in cash plus one contingent value right (CVR) per share for future milestone payments. The amendment extends the offer commencement timeline and modif
View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.